Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities
Net (loss) income	$ (6,682)	$ 3,784
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Impairment charge	5,766	0
Depreciation and amortization	7,317	6,849
Debt issuance costs amortization	33	48
Benefit from deferred income taxes	(346)	(108)
Gain on sale of assets	(101)	(9)
Gain on sale of business	(218)	0
Gain on purchase of business	(462)	0
Unrealized intercompany foreign currency transaction loss (gain)	907	(92)
Changes in operating assets and liabilities, net of businesses acquired:
Accounts receivable	2,670	5,223
Inventories	(10,054)	1,409
Other assets	225	378
Accounts payable	2,743	(2,355)
Customer deposits	259	953
Accrued expenses	(2,859)	(7,348)
Accrued pension and postretirement liabilities	(35)	(298)
Net cash (used in) provided by operating activities	(837)	8,434
Investing activities
Acquisition of businesses, net of cash acquired	(5,683)	(34,250)
Capital expenditures	(1,830)	(2,192)
Proceeds from disposal of business	218	0
Proceeds on sales of assets	131	113
Net cash used in investing activities	(7,164)	(36,329)
Financing activities
Payment of contingent consideration	(7,500)	(299)
Proceeds from short-term notes payable to bank	13,827	43,041
Repayments of short-term notes payable to bank	(13,827)	(45,729)
Proceeds from long-term debt	0	23,000
Repayments of long-term debt	(8,373)	(2,934)
Debt issuance costs	0	(682)
Dividends paid	(757)	(701)
Net proceeds from sales of common stock	5,678	1,632
Net cash (used in) provided by financing activities	(10,952)	17,328
Effect of exchange rate changes on cash	(764)	(510)
Net decrease in cash	(19,717)	(11,077)
Cash and cash equivalents at beginning of period	34,722	26,855
Cash and cash equivalents at end of period	$ 15,005	$ 15,778